Increase of PTH in post-menopausal osteoporosis;Aumento de los valores de PTH en la mujer con osteoporosis posmenopáusica

Revista Clinica Espanola

Volumn 211, Issue 7, 2011, Pages 338-343

  Cerda D ^a   Peris, P ^b   Monegal, A ^b   Albaladejo, C ^c   Martinez De Osaba M J ^b   Suris X ^a   Guanabens N ^b  

^a HOSPITAL GENERAL DE GRANOLLERS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Unidad de Reumatologia CAP Manso   (Spain)

Author keywords

25 hydroxyvitamin D; Postmenopausal osteoporosis; PTH

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; CALCIUM INTAKE; CALCIUM URINE LEVEL; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCALCIURIA; HYPERPARATHYROIDISM; KIDNEY FAILURE; MAJOR CLINICAL STUDY; NUTRITIONAL DEFICIENCY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPERPARATHYROIDISM, PRIMARY; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE;

EID: 79959349767     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2011.03.014     Document Type: Article

References (37)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. JAMA. 2001;285:785-95.
2. Fitzpatrick L. Secondary causes of osteoporosis. Mayo Clin Proc. 2002;77:453-68.
3. Jamal SA, Leiter RE, Bayoumi AM, Bauer DC, Cummings SR. Clinical utility of laboratory testing in women with osteoporosis. Osteoporos Int. 2005;16:534-40.
4. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab. 2002;87:4431-7. (Pubitemid 35247019)
5. Deutschmann HA, Weger M, Weger W, Kotanko P, Deutschmann MJ, Skrabal F. Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J Intern Med. 2002;252:389-97. (Pubitemid 36706570)
6. Lundgren E, Rastad J, Thurfjell E, Akerstron G. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery. 1997;21:287-94. (Pubitemid 27114448)
7. Eastell R, Arnold A, Brandi L, Brown EM, D'Amour P, Hanley DA, et al. Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Third International Workshop. J Clin Endocrinol Metab. 2009;94:340-50.
8. Weaver S, Doherty DB, Jiménez C, Perrier ND. Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism. World J Surg. 2009;33:2292-302.
9. Quesada JM, Sosa M. Vitamina D: más allá del tratamiento de la osteoporosis. Rev Clin Esp. 2008;208:173-4.
10. Sahota O, Gaynor K, Harwood RH, Hosking DJ. Hypovitaminosis D and functional hypoparathyroidism - the NoNoF (Nottingham Neck of Femur) study. Age Ageing. 2001;30:467-72. (Pubitemid 34071485)
11. Von Mühlen DG, Greenglade GA, Garland CF, Wan L, Barrett-Connor E. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: The Rancho Bernardo Study. Osteoporos Int. 2005;16:1721-6.
12. Pepe J, Romagnoli E, Nofroni I, Pacitti MT, De Geronimo S, Letizia C, et al. Vitamin D status as the major factor determinig the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int. 2005;16:805-12. (Pubitemid 40933597)
13. Mezquita-Raya P, Muñoz-Torres M, Luna JD, Luna V, López-Rodríguez F, Torres-Vela E, et al. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Miner Res. 2001;16:1408-15. (Pubitemid 32675192)
14. Aguado P, del Campo MT, Garcés MV, González-Casaus ML, Bernad M, Gijón-Baños J, et al. Low vitamin D levels in outpatients postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int. 2000;11:739-44.
15. Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004;35:312-9. (Pubitemid 38789179)
16. Cerdà Gabaroi D, Peris P, Monegal A, Albaladejo C, Martínez MA, Muxí A, et al. Search for hidden secondary causes in postmenopausal women with osteoporosis. Menopause. 2010;17:135-9.
17. González Macías J, Jodar E, Muñoz M, Díez Pérez A, Guañabens N, Fuster E. Factores de riesgo de la osteoporosis en mujeres atendidas en Atención Primaria y en consultas hospitalarias. Estudio OPINHO-PC. Rev Clin Esp. 2009;209:319-24.
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
19. Dawson-Hughes BN, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713-6. (Pubitemid 40933586)
20. Bushinsky DA. Calcium Nephrolithiasis. En: Favus MJ, editor. Primer on the metabolic bone disorders of mineral metabolism. 6.a ed. Washington: ASBMR; 2006. p. 456-60.
21. Mckane WR, Khosla S, Egan KS, Robins SP, Burritt MF, Riggs BL. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab. 1996;81:1699-703. (Pubitemid 26152448)
22. Nissenson RA, Jüppner H. Parathyroid hormone. En: Rosen CJ, editor. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 7.a ed. Washington: ASBMR; 2008. p. 123-7.
23. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
24. Rao DS, Agarwal G, Talpos GB, Phillips ER, Bandeira F, Mishra SK, et al. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res. 2002;17 Suppl 2:N75-80.
25. Silverberg SJ. Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res. 2007;22 Suppl 2:V100-4.
26. Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasisi, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004;35:312-9. (Pubitemid 38789179)
27. Arabi A, Baddoura AA, El-Rassi R, El-Hajj Fuleihan G. Age but not gender modulates the relationship between PTH and vitamin D. Bone. 2010;47:408-12.
28. Monchick JM, Gorgun E. Normocalcemic hyperparathyroidism in patients with osteoporosis. Surgery. 2004;36: 1242-6. (Pubitemid 39647540)
29. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:351-65.
30. Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by Cockcroft Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res. 2005;20:2105-15. (Pubitemid 41698774)
31. Rubin MR, Bilezikian JP, Mc Mahon DJ, Jacobs T, Shane E, Siris E, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93:3462-70.
32. Lowe H, McMahon J, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007;92:3001-5. (Pubitemid 47236362)
33. Siilin H, Rastad J, Ljunggren O, Lundgren E. Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity. J Clin Endocrinol Metab. 2008;93: 47-53.
34. Rejnmark L, Vestergaard P, Brot C, Mosekilde L. Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study. Calcif Tissue Int. 2011;88:238-45.
35. Pérez Castrillón JL. Prevención de fracturas no vertebrales con vitamina D oral y dosis dependencia. Un metaanálisis de ensayos clínicos aleatorizados. Rev Clin Esp. 2010;210: 42-3.
36. Sosa Hernández M, Gómez de Tejada Romero MJ. La medicina basada en la evidencia y los fármacos aprobados para el tratamiento de la osteoporosis. Papel del calcio y la vitamina D. Rev Clin Esp. 2009;209:25-36.
37. Moro-Álvarez MJ, Blázquez Cabrera JA. Osteoporosis en el varón. Rev Clin Esp. 2010;210:342-9.